Cobleigh相关文献与解析，生知库 | 链接生命科学的每一步

Shammo, Jamile; Owczarzak, Laura; Yun, Nicole K; Winkelman, Lois; Basu, Sanjib; Rao, Ruta; Ahmed, Amina; Dewdney, Summer; Cobleigh, Melody; Usha, Lydia

发表日期：2025

文献求助收藏

Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment

Eganelisib联合免疫检查点抑制剂疗法和化疗一线治疗转移性三阴性乳腺癌，可触发肿瘤微环境中的巨噬细胞重编程、免疫激活和细胞外基质重组。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2024-009160

Brenda C O'Connell ，Charley Hubbard ，Nora Zizlsperger ，Donna Fitzgerald ，Jeffrey L Kutok ，Judith Varner ，Robert Ilaria Jr ，Melody A Cobleigh ，Dejan Juric ，Kate H R Tkaczuk ，Anthony Elias ，Arielle Lee ，Shaker Dakhil ，Erika Hamilton ，Hatem Soliman ，Stephane Peluso

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

可溶性尿激酶型纤溶酶原激活物受体与多柔比星治疗乳腺癌患者的心脏毒性：一项前瞻性探索性研究

期刊:Cardiooncology

影响因子:3.2

doi:10.1186/s40959-023-00191-0

Chu, Jian; Tung, Lillian; Atallah, Issam; Wei, Changli; Cobleigh, Melody; Rao, Ruta; Feinstein, Steven B; Usha, Lydia; Banach, Kathrin; Reiser, Jochen; Okwuosa, Tochukwu M

Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study

更正：多柔比星治疗乳腺癌患者可溶性尿激酶型纤溶酶原激活物受体与心脏毒性：一项前瞻性探索性研究

期刊:Cardiooncology

影响因子:3.2

doi:10.1186/s40959-024-00205-5

Chu, Jian; Tung, Lillian; Atallah, Issam; Wei, Changli; Cobleigh, Melody; Rao, Ruta; Feinstein, Steven B; Usha, Lydia; Banach, Kathrin; Reiser, Jochen; Okwuosa, Tochukwu M

Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples

比较结肠活检、内镜采集和居家采集粪便样本中肠道微生物群的组成

期刊:Frontiers in Microbiology

影响因子:4.5

doi:10.3389/fmicb.2023.1148097

Nowicki, Christina; Ray, Lucille; Engen, Philip; Madrigrano, Andrea; Witt, Thomas; Lad, Thomas; Cobleigh, Melody; Mutlu, Ece A

微生物学

发表日期：2023

文献求助收藏

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

比较放疗联合或不联合曲妥珠单抗治疗HER2阳性导管原位癌保乳手术的疗效：一项III期临床试验

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.20.02824

Cobleigh, Melody A; Anderson, Stewart J; Siziopikou, Kalliopi P; Arthur, Douglas W; Rabinovitch, Rachel; Julian, Thomas B; Parda, David S; Seaward, Samantha A; Carter, Dennis L; Lyons, Janice A; Dillmon, Melissa S; Magrinat, Gustav C; Kavadi, Vivek S; Zibelli, Allison M; Tiriveedhi, Lavanya; Hill, Matthew L; Melnik, Marianne K; Beriwal, Sushil; Mamounas, Eleftherios P; Wolmark, Norman

Microbial dysbiosis reflects disease resistance in diverse coral species

微生物菌群失调反映了不同珊瑚物种的抗病能力

期刊:Communications Biology

影响因子:5.1

doi:10.1038/s42003-021-02163-5

MacKnight, Nicholas J; Cobleigh, Kathryn; Lasseigne, Danielle; Chaves-Fonnegra, Andia; Gutting, Alexandra; Dimos, Bradford; Antoine, Jendahye; Fuess, Lauren; Ricci, Contessa; Butler, Caleb; Muller, Erinn M; Mydlarz, Laura D; Brandt, Marilyn

微生物学

发表日期：2021

文献求助收藏

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

新发与复发性HER2阳性转移性乳腺癌：来自SystHERs注册研究的患者特征、治疗和生存情况

期刊:Oncologist

影响因子:4.2

doi:10.1634/theoncologist.2019-0446

Tripathy, Debu; Brufsky, Adam; Cobleigh, Melody; Jahanzeb, Mohammad; Kaufman, Peter A; Mason, Ginny; O'Shaughnessy, Joyce; Rugo, Hope S; Swain, Sandra M; Yardley, Denise A; Chu, Laura; Li, Haocheng; Antao, Vincent; Hurvitz, Sara A

Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells

STAT6 缺失导致 HER2+ 乳腺癌细胞发生锚定非依赖性生长和曲妥珠单抗耐药性

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0234146

Molly DiScala, Matthew S Najor, Timothy Yung, Deri Morgan, Abde M Abukhdeir, Melody A Cobleigh

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center

乳腺癌治疗中肿瘤测序和种系检测的配对应用：一家学术中心的经验

期刊:Cancer Reports

影响因子:1.9

doi:10.1002/cnr2.1287

Elliott, Elizabeth; Speare, Virginia; Coggan, James; Espenschied, Carin; LaDuca, Holly; Yussuf, Amal F; Burgess, Kelly; Gray, Phillip; Cobleigh, Melody; Rao, Ruta; Patel, Jeremy; Kuzel, Timothy; Buckingham, Lela E; Usha, Lydia

A prospective study of serum folate levels in patients with solid tumors treated with olaparib

前瞻性研究奥拉帕尼治疗实体瘤患者血清叶酸水平

Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment

Eganelisib联合免疫检查点抑制剂疗法和化疗一线治疗转移性三阴性乳腺癌，可触发肿瘤微环境中的巨噬细胞重编程、免疫激活和细胞外基质重组。

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

可溶性尿激酶型纤溶酶原激活物受体与多柔比星治疗乳腺癌患者的心脏毒性：一项前瞻性探索性研究

Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study

更正：多柔比星治疗乳腺癌患者可溶性尿激酶型纤溶酶原激活物受体与心脏毒性：一项前瞻性探索性研究

Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples

比较结肠活检、内镜采集和居家采集粪便样本中肠道微生物群的组成

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

比较放疗联合或不联合曲妥珠单抗治疗HER2阳性导管原位癌保乳手术的疗效：一项III期临床试验

Microbial dysbiosis reflects disease resistance in diverse coral species

微生物菌群失调反映了不同珊瑚物种的抗病能力

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

新发与复发性HER2阳性转移性乳腺癌：来自SystHERs注册研究的患者特征、治疗和生存情况

Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells

STAT6 缺失导致 HER2+ 乳腺癌细胞发生锚定非依赖性生长和曲妥珠单抗耐药性

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center

乳腺癌治疗中肿瘤测序和种系检测的配对应用：一家学术中心的经验